Mito Flashcards

1
Q

what is a primary mitochondrial disease?

A

Disease due to a mtDNA mutation- affects the mitochondrial respiratory chain and OXPHOS (Oxidative phosphorylation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the pathogenesis of mitochondrial disease?

A

Disease is due to- low energy production- ROS generation - reactive oxygen species- lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the incidence and age of onset of mitochondrial disease?

A

Mitochondrial diseases can be present at birth, butcan also occur at any age.Incidence:12.5 per 100,000 in adults4.7 per 100,000 in children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the phenotype of mitochondrial disease?

A

can affect any tissuemost affected are those with the highest energy demand e.g. brain and muscleCNSencephalopathyseizuresdementiastroke-like episodeataxiadepressionEYEopthalmoplegiacataractsptsosisoptic atrophyCARDIAChypertrophic cardiomyopathydilated cardiomyopathyGIdysphagiapsuedo obstructionconstipationhepatic failureENDOCRINEdiabeteshypothyrpidismgonadal failurePNSmyopathyneuropathyHEARINGsensironeural deafness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe the mitochondrial genome

A

replicates independently of nDNAcircular- 16.6Kb long and codes 37 genes- 13 mitochondrial peptides, 22tRNAs and 2rRNAsno introns and so splicing is not a mechanism of disease.maternally transmittedeach cell has 100-100,000’s of copeis of the MT genomecan be heterplasmic or homoplasmicThe level of mutant mtDA can vary within individuals from the same family and between tissues in the same individual due to the mitochondrial bottleneck where WT and Mut mt is randonly distributed to daughter cells - this can be uneven resultin in cell lines with higher or lower levels of heteroplasmy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

why may a mt variant not be detected in blood?

A

some variants are lost from blood due to rapid mitotic division.e.g. m.3243A>G- most common mtDNA mut and found in MELAS and MIDD- this makes genetic testing difficult and need to carefully consider the choice of tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the function of the mitochondria?

A

Produces energy for the cell via the oxidative phopshorylation pathway (OXPHOS)also involved in ca2+ signalling, cellular metabolism, haem and steroid synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

why is there a high mutation rate in mitochondria?

A

NAME?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is OXPHOS?

A

the OXPHOS pathway transfers electrons through e- transport carriers to create an electrochemical gradient across the MM which is used to drive the production of ATP from ADP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the heteroplasmy threshold for mitochondrial disease.

A

For mtDNA variants to manifest with a phenotype there is a threshold level of mutant that needs to be present~40-60% for mtDNA deletions~90% for point mutations in mtDNA tRNAs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the 3 mitochondrial deletion diseases and there characteristics?

A
  • de novo- heteroplasmic- several genes deletedPearsons- anemia, pancytopenia, lacic acidosis, pancreatic failure (onset in infancy)Kearns-Sayre- myopathy deafness, opthalmoplegia, cardiomyopathy (adult onset)CPEO- opthalmoplegia, ptosis, imparied eye movement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are secondary mitochondrial disease?

A

due to nDNA defects and involves genes that have a direct effect on the function of the mitchondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give an example of nDNA mutation affecting mtDNA maintenance and expression

A

direct effects e.g. POLG, POL2 (specific mtDNA polymerase and TWNKindirect effect e.g. SLC25A4 and RRM2B- affect nucleoside transport, synthesis and salvage- mtDNA needs a supply of dNTPs for replication, im mitotically active tissue this is provided by import from the cytoplasm. In non-mitotically active tissue the dNTPS are obtained from the salvage pathway- these differences result in tissue specific phenotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Give an example of nDNA mutation resulting in mt dysfunction without affecting mtDNA maintenance or function?

A

Mutations in the assembly factors of the respiratory chain e.g SURF mutations in MELASmutations in genes involved in mt dynamics e.g. fusion and fission which in turn perturbs the number and distribution of mitochondriae.g. MFN2 in CMT (fusion)OPA1 in optic atrophy (fission)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the mtDNA point mutation diseases?

A

maternally inherited (except AID- sporadic)heteroplasmicmost common mut is m.3243A>G in MEALS and MIIDMELAS- myopahty, encephalopathy, acidosis and stroke like episodesMERRF- myoclonic epilepsy and ragged red fibresNARP- neurogenic weakness, ataxia and retinitis pigmentosaMIDD- maternally inherited diabetes and deafnessAID - amnio glycoside induced deafnessLHON- leber hereditary optic neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is mt disease associated with neurodegenerative disorders?

A

Parkinsons- mtDNA deletions are observed in neurons of parkinsons patients and mutations in genes involved in mitochondrial function are mutated in early onset familal parkinsonsalzheimers - respiratory chain dysfunction due to mtDNA mut found in neurons of patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How can mt be used as a cancer biomarker?

A

WARBURG EFFECTtumours preferentially use glycolysis to produce ATP and injury of the respiratory chain is a key event in carcinogenesismt genome could be used as an early biomarker of cancer as mutation does not appear to be restricted to certain cancer types.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What approach is used for diagnosis of mitochondrial disease?

A

considers phenotype and family history and often requires several approaches including biochemistry, immunohistochemistry, nuclear and mitochondrial DNA testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what are the requirements and usage of histochemistry in mitochondrial disease diagnosis?

A

Needs muscle biopsycan stain for ragged red fibres using a gromi trichome stain (sub sarcolemma collection of MT)can test for the activity of specific mitochondrial enzymes- SDH (succinate dehydrogenase) loss is indicative of a complex II deficiency- COX (oxidase) subunitss encoded by both nuclear and mitchondrial DNANormal IHC does not exclude a diagnosis and can see age related mitchondrial defects so need to consider this in older patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are the requirements and usage of biochemistry in mitochondrial disease diagnosis?

A

requires muscle biopsy- want a sample enriched for mtcan measure rates of flux, substrate oxidation and AT|P generation and can measure the level of activity of each XOPHOS substrate seperatelyNeed a lot of sample (50-100mg) may not detect subtle OXPHOS deficiencies especially when mosaic and only a few muscle fibres are affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How are mt DNA rearrangements detected?

A

NAME?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How are mt point mutations detected?

A

common mt mutations can be detected by sequencing- technique need to be sensitive to detect low heteroplasmy (mosaicism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is mutation searching for mitchondrial disease?

A

real time PCR can be used to detect mt copy number- an increase in mtDNA CN suggests that the moelcualr effect is likely to be located in the mitochondrial genome, hence whole mtDNA genome sequencing may be consideredneed to consider heteroplasmy and use a technique that is sensitive to low level mutation85-90% of patients with a suspected primary mitochondrial disease do not have a pathogenic mutation detected in the mdt genome highlighting the importance of considering an nDNA mutation- screen genes involved in OXPHOS or mt genome maintenanceNGS is proving pivital in mt disease diagnosis and >250 nDNA genes have now been shown to cause mitochondrial disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the considerations for mt disease testing (sample type)?

A

Muscle is best but may not be practical or desired by the patient- however failure make a diagnosis in blood does not mean the patient does not have mt disease, just that the mutation is not detectable in blood- many labs include caveat on their reports to this affect and request a muscle sample if a diagnosis is still strongly suspected.Urine can be used for some mutations e.g. m.3243A>G in MELAS as levels in urine correspond with the level in blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Give examples of the importance of tissue type in mt disease diagnosis

A

CPEO- mtDNA deletions are only detected in skeletal muscleKSS- mtDNA deletions can be detected in all tissue so blood can be testedLHON- pateints have homoplasmic mutations and these are inherited by all mother offspring but only 50% of males and 10% of female offspring express the phenotpye demonstrating the importance of other genetic modifiers in the expression of mitchondrial disease

26
Q

what are the considerations for prenatal diagnosis for mitochondrial disease?

A

mtDNA heteroplasmy can make interpretation of prenatal results complicated- a heteroplasmic point mutation can be transmitted in variable amounts- the level of heteroplasmy in a CVS sample may not accurately reflect the heteroplasmy in the fetus- if a mutation is detected it is not possible to predict the severity of the disease or if the baby will be affected at all.

27
Q

What are the options for presenting transmission of mitochondrial disease?

A

oocyte donation/nuclear transferwhere the nuclear genome from the oocyte of an affected mother in transfered into a donor enucleated oocyte with healthy mtDNA3 parent babies

28
Q

What are the treatments for mitochondrial disease?

A

No effective treatment so emphasis is on prevention by PGD/PNDgermline therapies are being developed to limit the carry over of mitochondrial DNA-It has been demonstrated to be technically possible to transmit <3% of maternal mtDNA with spindle chromosomal transfer in primates and pronuclear transfer in preimplantation human embryostherapies targeted at correcting mtDNA mutations are difficult to develop as they need to be specific and be able to cross the mitochondrial double membrane- 1 way that has been developed to overcome this is to engineer allotypic expression of mt genes where the WT gene is expressed in the nucleus but includes a mitochondrial targeting sequence

29
Q

When was mitochondrial donation licenced in the UK?

A

Feb 2015- house of lords voted to allow British researchers to pursue investigation into fertility treatment using mtDNA replacement therapy. Backed by the HEFA who granted licences for experimental use of this technique in humans2018- HEFA grants a licence for mitochondrial donation to the wellcome centre for mitochondrial research. UK becomes the first country to to leaglly offer the procedure to a patient

30
Q

what is the mitochondrial bottleneck?

A

During the production of oocytes a random selection of mt are transferred to each oocyte- can be uneven distribution between mut and WT- oocyte maturation is associated with the rapid replication of the mtDNA populationthe restriction-amplification event can lead to random shift of mtDNA load between generations and is responsible for the variation in heteroplasmy levels between affected offspring and mothers

31
Q

How large is the mt genome, how many genes does it code for and how many protein coding genes?

A

16.6kb37 genes13: all proteins involved in OxPhos. Remainder are 2 rRNAs and 22 tRNAs.

32
Q

What is unusual about mitochondrial termination codons?

A

They are added post-transcriptionally

33
Q

Why does mtDNA have a higher mutation rate(10x) than nuclear DNA?

A

It is located closer to the sites of reactive oxygen species generation, so more oxidative damage occurs.

34
Q

What three classes of disease are related to mitochondrial dysfunction?

A

Primary mt diseaseNeurodegenerationCancer

35
Q

What is the carrier rate for mitochondrial disease?

A

1/200

36
Q

What is the required clinical threshold for deleted mtDNA molcules

A

50-60%

37
Q

What is the required clinical threshold for point mutation in tRNA genes?

A

> 90%

38
Q

Which organ systems are frequently affected? Why?

A

Renal tubulesSkeletal muscleCardiac muscleNeuronsCochlear hair cellsThey are highly post-mitotically active and have high energy demands

39
Q

What is the difference in age at presentation between mtDNA mutations and nDNA mutations?

A

mtDNA mutations tend to appear in childhood; nDNA mutations in adulthood.

40
Q

Name the common mtDNA disorders. State whether they show disease in heteroplasmic or homoplasmic forms, and name their common mutation.

A

Deletion disorders:KSS - Several deleted genes, heteroplasmicCPOE - Several deleted genes, heteroplasmicPearson - Several deleted genes, heteroplasmicPoint mutation disorders:LHON - MT-ND1 (m.3460G>A), ND4 (m.11778G>A), ND6 (c.14484T>C), hetero and homoplasmicMELAS - MT-TL1 (m.3243A>G) HeteroplasmicMERFF - MT-TK (m.8344A>G) HeteroplasmicMIDD - MT-TL1 (m.3243A>G), HeteroplasmicAID - MT-RNR1 (m.1555A>G), hetero and homoplasmicLeigh syndrome - MT-ATP6 (m.8993T>C)NARP - MT-ATP6 (m.8993T>G) Heteroplasmic

41
Q

For each mt referral, state whether the variant can be detected in blood or muscle.

A

KSS - MusclePearson - BloodCPOE - MuscleLHON - BloodMELAS - MuscleMERFF - Blood or MuscleAID -BloodMIDD - MuscleLeigh - BloodNARP - Blood

42
Q

Name some nuclear genes associated with mitochondrial DNA expression and maintenance.How do they cause disease?

A

POLG, POLG2, SLC25A4They reduce the amount of ATP available to the mitochondria, through lack of nucleoside salvage and supply, and force the cells to enter lactic acidosis.

43
Q

Name some nuclear genes that indirectly cause mitochondrial diseaseHow do they cause disease?

A

SURF1 causes Leigh syndrome - affects assembly factors of the respiratory chain.MFN2 causes CMT2A by affecting fusion.OPA1 causes LHON by affecting fission

44
Q

How can mtDNA mutations relate to ageing?

A

Multiple mutations accumulate over the lifetime of a person and can cause cellular dysfunction.

45
Q

How can mtDNA act as a cancer biomarker?

A

Increased expression of mitochondrial genes is indicative of increased cellular activity. Tumours are ATP-hungry and mutations affecting the respiratory machinery is a key event in carcinogenesis.

46
Q

What histochemical methods can be used for mitochondrial diagnosis?

A

Stain for enzymes in the OxPhos pathway, or for ragged red fibres. Need muscle biopsy.

47
Q

What biochemical methods can be used for mitochondrial diagnosis?

A

Can test rates of oxidation and ATP production.Need muscle biopsy

48
Q

What genetic methods can be used for mitochondrial diagnosis?

A

Mitochondrial rearrangementsLR_PCR, Southern blotCommon point mutationsRestriction digest if mutation affects restriction siteSequencingNovel mutationsSequencingRT-PCR

49
Q

What needs to be taken into account when testing?

A

Tissue type being screenedPredicted level of heteroplasmy/homoplasmySensitivity of testAge of patient

50
Q

What alternative tissue can be used as an alternative to muscle?

A

Urine - especially for m.3243A>G in MELAS/MIDD.

51
Q

What considerations need to be taken into account when performing prenatal diagnosis?

A

CVS cells may not reflect foetus.Cannot predict accurately how severely the child will be affected

52
Q

what are the reproductive options for women with a pathogenic mt DNA mutation?

A
  1. oocyte donation2. prenatal diagnosis- suitable for patients with low levels of heterpolasmy3. PIGD- embryo sampled at cleavage or balstocystr stage- suitable for patients with low levels of heteroplasmy4. mitochondrial donation- fertilised egg and removal of nuclear genome and transfered to a enucleated feritlised donor oocyte with mt DNA remaining- sutiable for homolasmic or high heterplasmy patients
53
Q

what is a mitochondria

A

Sub-cellular organelles responsible for producing the majority of cellular ATP via the oxidative phosphorylation pathwayMtDNA is a 16.6kb circular dsDNA molecule encoding for 37 genes: 13 polypeptides of the OXPHOS system, 2 ribosomal RNAs and 22 tRNAsMtDNA is almost exclusively transmitted through the maternal line.

54
Q

discuss the mutation rate in mitochondria

A

Higher mutation frequency (~10x) than nDNAThe mtDNA can all be identical (homoplasmy) or a mixture of two or more mt genotypes (heteroplasmy). The percentage level of mutant mtDNA may vary among individuals within the same family, and also among organs and tissues within the same individual

55
Q

Discuss mutation thresholds in mt

A

In cases of heteroplamic muts there is typically a threshold level where the mutation becomes clinically significant 50-60% for deleted mtDNA molecules; >90% point mutations in tRNA.

56
Q

describe clinical features of MELAS (Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes)

A

Myopathy, encephalopathy, lactic acidosis, stroke-like episodesMT-TL1 m.3243A>G and m.3271T>C

57
Q

describe clinical features of MERFF (Myoclonic epilepsy and ragged-red fibres)

A

Myoclonic epilepsy, myopathy, cereberal ataxia MT-TK m.8344A>G and m.8356T>C

58
Q

describe clinical features of NARP (Neurogenic weakness, ataxia and retinitis pigmentosa)

A

Sensory neuropathy, ataxia, retinitis pigmentosaMT-ATP6 m.8993T>G

59
Q

describe clinical features of Leigh/Leigh like

A

Encephalopathy, lactic acidosis MT-ATP6 m.8993T>C

60
Q

How are mt disorders diagnosed

A

multidiscipline approach involving clinical assessment, family history, biochemical testing, histopathological examination and direct molecular testing.Histochemistry specific mt enzymes.Biochemistry measure rates of flux, substrate oxidation and ATP productionMolecular genetics long-range PCR is typical front line test ( point mut, dels, dups and multiple mtDNA dels)